Founder of Blueprint. I help companies stop sending emails nobody wants to read.
The problem with outbound isn't the message. It's the list. When you know WHO to target and WHY they need you right now, the message writes itself.
I built this system using government databases, public records, and 25 million job posts to find pain signals most companies miss. Predictable Revenue is dead. Data-driven intelligence is what works now.
Your GTM team is buying lists from ZoomInfo, adding "personalization" like mentioning a LinkedIn post, then blasting generic messages about features. Here's what it actually looks like:
The Typical Merative SDR Email:
Why this fails: The prospect is an expert. They've seen this template 1,000 times. There's zero indication you understand their specific situation. Delete.
Blueprint flips the approach. Instead of interrupting prospects with pitches, you deliver insights so valuable they'd pay consulting fees to receive them.
Stop: "I see you're hiring compliance people" (job postings - everyone sees this)
Start: "Your Arizona Medicaid backlog hit 67 days in November - 22 days over federal requirements" (CMS public data with specific metrics)
PQS (Pain-Qualified Segment): Reflect their exact situation with such specificity they think "how did you know?" Use government data with dates, record numbers, facility addresses.
PVP (Permissionless Value Proposition): Deliver immediate value they can use today - analysis already done, deadlines already pulled, patterns already identified - whether they buy or not.
These messages demonstrate precise understanding of prospect situations and deliver actionable intelligence. Ordered by quality score (highest first).
Monitor site-level enrollment velocity from ClinicalTrials.gov updates and alert pharma/CRO clients when a previously active site suddenly stops enrolling patients. Provide full PI contact information for immediate follow-up.
You're surfacing a potential crisis they haven't noticed yet. The specificity of enrollment numbers by month plus complete PI contact info proves you're tracking their trial closely and enabling immediate action with one decision.
This play requires tracking site-level enrollment velocity from ClinicalTrials.gov updates combined with internal site contact databases and historical performance metrics.
This synthesis of public trial data with proprietary site performance tracking is unique to Merative's clinical trial platform.Identify comparable trials with strong enrollment at major academic medical centers where the prospect has no site presence. Provide specific enrollment numbers and offer direct contact information for trial coordinators.
You're showing them a proven opportunity they missed. The combination of comparable trial performance data plus market size justification makes the geographic gap obvious. Offering the coordinator's contact info enables immediate expansion planning.
This play requires identifying comparable trials from ClinicalTrials.gov and matching site performance with market opportunity analysis, plus internal site coordinator contact databases.
This synthesis of public trial data with proprietary site performance tracking and coordinator networks is unique to Merative's RWE platform.Identify high-performing sites in the prospect's network, then find nearby sites with comparable patient volumes that aren't currently in their trial network. Provide specific enrollment data and complete contact information.
You're building on their existing success by showing them adjacent opportunities they can activate quickly. The geographic proximity makes implementation easy, and the comparable enrollment data proves the sites are qualified.
This play requires site-level enrollment data from ClinicalTrials.gov combined with geographic proximity analysis and internal site performance tracking across multiple trials.
This synthesis of public trial data with proprietary multi-trial site performance benchmarking is unique to Merative's clinical trial platform.Cross-reference eligible patient population data with current site distribution to identify geographic misalignments. Provide specific alternative sites with proven trial experience and enrollment performance.
You're showing them they're investing resources in the wrong geography. The population data justifies the opportunity, and providing ready-to-contact sites with track records makes expansion planning immediate.
This play requires combining patient population epidemiology data with site location mapping and internal trial history databases showing site infrastructure and enrollment performance.
This synthesis of public health data with proprietary site performance tracking is unique to Merative's RWE platform.Identify adjacent geographies with higher disease prevalence where the prospect has no site presence. Provide specific sites with proven enrollment performance in comparable trials and offer PI contact information.
You're combining epidemiology data with site performance history to show them an untapped patient pool. The prevalence data justifies the opportunity, and the proven site performance de-risks expansion.
This play requires combining CDC diabetes prevalence maps with ClinicalTrials.gov site data and internal site performance tracking databases.
This synthesis of public health data with proprietary site performance history is unique to Merative's clinical trial platform.Identify peer states that solved identical Medicaid processing challenges using technology implementations. Provide specific before/after metrics and offer implementation details including technology specs and timelines.
You're providing a proven playbook from a peer state that solved the exact problem they're facing. The specific metrics show concrete results, and offering implementation details makes this actionable intelligence they can use today.
This play requires identifying state Medicaid technology implementations from government procurement and performance reports, combined with internal customer success case studies.
This synthesis of public performance data with proprietary implementation knowledge is unique to Merative's government services platform.Track Medicare Advantage enrollment changes and Star Rating movements for competing plans in the same counties. Connect member movement directly to quality score changes and offer analysis of which specific measures drove competitor gains.
You're providing direct competitive intelligence showing exactly how competitors are winning members in their market. The connection between quality improvements and enrollment gains makes the ROI of quality investment concrete.
Benchmark current site enrollment performance against their own historical capacity from prior trials. Identify underutilized sites and quantify the enrollment opportunity from optimizing existing infrastructure before expensive expansions.
You're showing them they're leaving enrollment on the table at sites they're already paying for. Benchmarking against their own history (not industry averages) makes the underperformance undeniable and actionable.
This play requires tracking historical site performance across multiple trials to establish site-specific capacity benchmarks, then comparing current performance to historical averages.
This longitudinal site performance tracking is unique to Merative's clinical trial platform.Compare enrollment performance across sites within the same region to identify geographic capacity mismatches. Offer expansion opportunities in higher-performing cities where prospect has no capacity.
You're showing them a quantified enrollment gap in their own backyard. The 2.3x performance difference makes the opportunity obvious, and asking a simple yes/no question for site contacts removes all friction.
This play requires site enrollment data from ClinicalTrials.gov combined with internal site capacity and infrastructure databases.
This synthesis of public enrollment data with proprietary site infrastructure tracking is unique to Merative's RWE platform.Analyze all HEDIS measures to identify the top 5 quality gaps versus regional benchmarks, quantify their contribution to Star Rating underperformance, and offer member-level intervention priorities.
You're providing a comprehensive diagnostic showing exactly where they're losing Star Rating points. The 68% contribution metric focuses their attention on the highest-impact opportunities, and offering member intervention priorities makes this immediately actionable.
Identify upcoming Medicaid renewal volumes and calculate the processing backlog that will result at current capacity levels. Focus on states where renewal surge will exceed processing capacity within 30-60 days.
You're showing them a predictable crisis they can still prevent. The forward-looking math makes the capacity gap undeniable, and asking about staffing planning positions you as a resource for solving it.
Identify peer states that achieved dramatic processing improvements using temporary augmentation strategies. Provide specific metrics on backlog reduction and offer implementation details including staffing models and technology configurations.
You're providing a concrete success story from a peer state with comparable scale. The 72-hour timeframe shows rapid results are possible, and offering their staffing model and tech specs makes this immediately actionable.
This play requires identifying state processing innovations from government reports combined with internal customer network knowledge of implementation approaches.
This synthesis of public performance data with proprietary peer network intelligence is unique to Merative's government services platform.Analyze public backlog data combined with federal Medicaid processing patterns to identify the percentage of applications stuck in resubmission cycles due to documentation issues. Quantify the processing delay impact and ask about tracking root causes.
You're surfacing a root cause insight they likely don't have visibility into. The 23% figure shows documentation is a major driver, and the 28-day delay per resubmission quantifies the cost. Asking about tracking positions you as helping them prevent the issue.
This play requires analyzing public backlog data combined with federal Medicaid processing patterns and internal analytics to infer documentation issues and delay impacts.
This synthesis of public data with proprietary pattern analysis is unique to Merative's benefits administration platform.Identify Medicare Advantage plans with the steepest year-over-year HEDIS declines compared to market peers. Quantify the Star Rating impact and ask about root cause investigation.
You're showing them they're the worst performer in their market on a high-impact measure. The 0.4 Star Rating point cost makes the urgency real, and asking about root cause positions you as helping them solve it rather than just pointing out the problem.
Identify state Medicaid agencies with eligibility processing times exceeding federal requirements. Show the trend (getting worse) and quantify the compliance risk with CMS corrective action.
You're connecting operational metrics to regulatory risk. The trend from 38 to 67 days shows it's deteriorating, and the 22-day overage makes the federal compliance violation concrete. This creates urgency beyond just operational efficiency.
Identify Medicare Advantage plans with year-over-year HEDIS declines on high-weight measures. Quantify the specific point gap versus regional average and the future Star Rating impact starting in 2026.
You're showing them a specific quality measure decline with verifiable numbers and connecting it to future financial impact. The 2026 Star Rating timeline creates urgency to act now, and asking about ownership shows you understand this needs executive attention.
Identify Medicare Advantage plans that dropped below critical Star Rating thresholds on high-impact measures. Focus on single measures that could trigger an overall rating drop.
You're showing them they're one point below a critical threshold that affects their overall Star Rating. The single measure focus makes the intervention clear, and asking about the pharmacy outreach program shows you understand the solution domain.
Identify states with Medicaid application backlogs exceeding federal limits AND growing month-over-month. Show the trend acceleration and ask about capacity planning.
You're showing them the backlog is accelerating, not stabilizing. The 3.2x comparison to January baseline and the 8% monthly growth rate make the trajectory unsustainable. Asking about case worker capacity shows you understand the resource constraint.
Track quarterly Medicare Advantage enrollment changes and connect member losses to Star Rating declines. Focus on plans with the largest enrollment drops in their market.
You're connecting two data points they might not have linked: member loss and quality score decline. The largest quarterly decline in market creates competitive pressure, and asking about mapping loss to quality scores positions you as helping them understand causation.
Compare HEDIS performance on high-impact measures to direct competitors operating in the same counties. Quantify the gap and connect to Star Rating impact and member retention.
You're providing direct competitive intelligence showing exactly how much they're underperforming versus a named competitor in their market. The 12-point gap is concrete, and connecting it to Star Rating points and member retention makes the business impact clear.
Old way: Spray generic messages at job titles. Hope someone replies.
New way: Use public data to find companies in specific painful situations. Then mirror that situation back to them with evidence.
Why this works: When you lead with "Your Arizona Medicaid backlog hit 67 days in November - 22 days over federal requirements" instead of "I see you're hiring for case management roles," you're not another sales email. You're the person who did the homework.
The messages above aren't templates. They're examples of what happens when you combine real data sources with specific situations. Your team can replicate this using the data recipes in each play.
Every play traces back to verifiable public data. Here are the sources used in this playbook:
| Source | Key Fields | Used For |
|---|---|---|
| CMS Hospital Quality Reporting (HCAHPS & IQR) | facility_name, hcahps_score, patient_satisfaction, safety_of_care, quality_star_rating | Hospital quality metrics and patient outcomes |
| CMS Provider Data Catalog - Outpatient Imaging Efficiency | provider_name, imaging_procedure_type, ct_scan_costs, mri_costs, imaging_utilization_rates | Imaging workflow efficiency and cost optimization |
| Medicare Advantage Contract & Enrollment Data | plan_name, contract_id, enrollment_count, market_penetration_rate, hedis_measures, service_area | MA plan performance and member analytics |
| Medicaid Data Collection Tool (MDCT) & T-MSIS | state, beneficiary_demographics, beneficiary_eligibility, medical_expenditures, utilization_data | Medicaid beneficiary analytics and program integrity |
| Public Medicaid & CHIP Eligibility Snapshot | state, total_medicaid_enrollment, application_volume, processing_timelines, renewal_outcomes | Medicaid enrollment trends and processing efficiency |
| CMS Medicaid Managed Care Program Annual Reports (MCPAR) | plan_name, state, enrollment_data, prior_authorization_metrics, quality_measures, financial_performance | MCO operational and financial metrics |
| FDA Real-World Evidence Data & Clinical Trial Resources | trial_identifier, patient_demographics, clinical_outcomes, adverse_events, real_world_data_source | Clinical trial enrollment and RWE for FDA submissions |
| AFCARS - Adoption and Foster Care Analysis System | state, children_entering_foster_care, demographics, living_arrangements, permanency_plans | Child welfare outcomes tracking and federal accountability |
| ACF Child Welfare Outcomes Dashboard | state, child_safety_indicators, permanency_indicators, maltreatment_recurrence, time_to_permanency | Child welfare performance metrics for compliance |
| ClinicalTrials.gov | trial_identifier, site_locations, enrollment_status, principal_investigator, patient_demographics | Clinical trial site performance and enrollment tracking |
| CDC Epidemiology Data | disease_prevalence, geographic_distribution, demographic_patterns | Patient population analysis for trial site selection |